Biotronik has enrolled the first patient in the second arm of the BIO-CONDUCT study to evaluate the Solia CSP S pacing lead for left bundle branch area pacing (LBBAP).
The EP PASSION project successfully transitioned the Solia S cardiac lead post-approval study to real-world data (RWD), demonstrating the feasibility of using claims data for device surveillance.
The FDA has granted approval for Biotronik's Selectra 3D catheter, used with the Solia S lead, for left bundle branch area pacing (LBBAP).
The FDA has approved Biotronik's lead and catheter system for left bundle branch area pacing (LBBAP), offering a new option for physiological pacing.
The FDA has granted approval for Biotronik's Selectra 3D catheter and Solia S lead system for left bundle branch area pacing (LBBAP).
Biotronik received FDA approval for its Selectra 3D catheter and Solia S lead, making them the first stylet-driven system approved for Left Bundle Branch Area Pacing (LBBAP).